These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 26256101)

  • 1. Norovirus immunology: Of mice and mechanisms.
    Newman KL; Leon JS
    Eur J Immunol; 2015 Oct; 45(10):2742-57. PubMed ID: 26256101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norovirus Infection: Replication, Manipulation of Host, and Interaction with the Host Immune Response.
    Sarvestani ST; Cotton B; Fritzlar S; O'Donnell TB; Mackenzie JM
    J Interferon Cytokine Res; 2016 Apr; 36(4):215-25. PubMed ID: 27046239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norovirus Regulation by Host and Microbe.
    Baldridge MT; Turula H; Wobus CE
    Trends Mol Med; 2016 Dec; 22(12):1047-1059. PubMed ID: 27887808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human norovirus infection and the acute serum cytokine response.
    Newman KL; Moe CL; Kirby AE; Flanders WD; Parkos CA; Leon JS
    Clin Exp Immunol; 2015 Nov; 182(2):195-203. PubMed ID: 26178578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in understanding of the innate immune response to human norovirus infection using organoid models.
    Mboko WP; Chhabra P; Valcarce MD; Costantini V; Vinjé J
    J Gen Virol; 2022 Jan; 103(1):. PubMed ID: 35077345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT1-dependent innate immunity to a Norwalk-like virus.
    Karst SM; Wobus CE; Lay M; Davidson J; Virgin HW
    Science; 2003 Mar; 299(5612):1575-8. PubMed ID: 12624267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial.
    Lindesmith LC; Ferris MT; Mullan CW; Ferreira J; Debbink K; Swanstrom J; Richardson C; Goodwin RR; Baehner F; Mendelman PM; Bargatze RF; Baric RS
    PLoS Med; 2015 Mar; 12(3):e1001807. PubMed ID: 25803642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-existing immunity to norovirus GII-4 virus-like particles does not impair de novo immune responses to norovirus GII-12 genotype.
    Tamminen K; Huhti L; Vesikari T; Blazevic V
    Viral Immunol; 2013 Apr; 26(2):167-70. PubMed ID: 23438469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The major targets of acute norovirus infection are immune cells in the gut-associated lymphoid tissue.
    Grau KR; Roth AN; Zhu S; Hernandez A; Colliou N; DiVita BB; Philip DT; Riffe C; Giasson B; Wallet SM; Mohamadzadeh M; Karst SM
    Nat Microbiol; 2017 Dec; 2(12):1586-1591. PubMed ID: 29109476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norovirus-Specific CD8
    Pattekar A; Mayer LS; Lau CW; Liu C; Palko O; Bewtra M; Consortium H; Lindesmith LC; Brewer-Jensen PD; Baric RS; Betts MR; Naji A; Wherry EJ; Tomov VT
    Cell Mol Gastroenterol Hepatol; 2021; 11(5):1267-1289. PubMed ID: 33444817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A working model of how noroviruses infect the intestine.
    Karst SM; Wobus CE
    PLoS Pathog; 2015 Feb; 11(2):e1004626. PubMed ID: 25723501
    [No Abstract]   [Full Text] [Related]  

  • 12. Norovirus in symptomatic and asymptomatic individuals: cytokines and viral shedding.
    Newman KL; Moe CL; Kirby AE; Flanders WD; Parkos CA; Leon JS
    Clin Exp Immunol; 2016 Jun; 184(3):347-57. PubMed ID: 26822517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular pathology of noroviruses.
    Karst SM; Zhu S; Goodfellow IG
    J Pathol; 2015 Jan; 235(2):206-16. PubMed ID: 25312350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune mechanisms responsible for vaccination against and clearance of mucosal and lymphatic norovirus infection.
    Chachu KA; LoBue AD; Strong DW; Baric RS; Virgin HW
    PLoS Pathog; 2008 Dec; 4(12):e1000236. PubMed ID: 19079577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic susceptibility to norovirus infection].
    Ruvoën N; Le Pendu J
    Pathol Biol (Paris); 2013 Jan; 61(1):28-35. PubMed ID: 23399413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norovirus encounters in the gut: multifaceted interactions and disease outcomes.
    Hassan E; Baldridge MT
    Mucosal Immunol; 2019 Nov; 12(6):1259-1267. PubMed ID: 31501514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the homo- and heterotypic immune responses after natural norovirus infection.
    Rockx B; Baric RS; de Grijs I; Duizer E; Koopmans MP
    J Med Virol; 2005 Nov; 77(3):439-46. PubMed ID: 16173019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norovirus infections and seroprevalence of genotype GII.4-specific antibodies in a Spanish population.
    Carmona-Vicente N; Fernández-Jiménez M; Ribes JM; Téllez-Castillo CJ; Khodayar-Pardo P; Rodríguez-Diaz J; Buesa J
    J Med Virol; 2015 Apr; 87(4):675-82. PubMed ID: 25655810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses.
    Mumphrey SM; Changotra H; Moore TN; Heimann-Nichols ER; Wobus CE; Reilly MJ; Moghadamfalahi M; Shukla D; Karst SM
    J Virol; 2007 Apr; 81(7):3251-63. PubMed ID: 17229692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norovirus virus-like particle vaccines for the prevention of acute gastroenteritis.
    Richardson C; Bargatze RF; Goodwin R; Mendelman PM
    Expert Rev Vaccines; 2013 Feb; 12(2):155-67. PubMed ID: 23414407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.